Work

Abstract B161: PIK3CA mutations H1047R are associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials.

Year: 2011

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-11-b161

Authors: Filip Janku, Aung Naing, Vanda T. Stepanek, Gerald S. Falchook, David S. Hong, Apostolia M. Tsimberidou, Siqing Fu, J. Jack Lee, Rajyalakshmi Luthra, Jennifer J. Wheler, Razelle Kurzrock

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2054536628

Cites:

Cited by: 3

Related to: 10